Sumitomo Mitsui Trust Group
VRTX icon

Sumitomo Mitsui Trust Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304M Sell
611,907
-2,541
-0.4% -$1.13M 0.17% 99
2026
Q1 		$274M Sell
614,448
-40,022
-6% -$18.7M 0.18% 108
2025
Q4 		$297M Sell
654,470
-46,203
-7% -$19.9M 0.17% 112
2025
Q3 		$274M Buy
700,673
+45,623
+7% +$19.1M 0.16% 126
2025
Q2 		$292M Buy
655,050
+11,063
+2% +$5.1M 0.18% 114
2025
Q1 		$312M Sell
643,987
-15,546
-2% -$7.24M 0.22% 98
2024
Q4 		$266M Sell
659,533
-12,565
-2% -$5.82M 0.18% 115
2024
Q3 		$313M Buy
672,098
+6,716
+1% +$3.23M 0.22% 93
2024
Q2 		$312M Sell
665,382
-53,028
-7% -$23M 0.23% 85
2024
Q1 		$300M Buy
718,410
+7,794
+1% +$3.29M 0.21% 102
2023
Q4 		$289M Sell
710,616
-968
-0.1% -$358K 0.21% 97
2023
Q3 		$247M Sell
711,584
-10,457
-1% -$3.66M 0.2% 109
2023
Q2 		$254M Sell
722,041
-123,186
-15% -$41.5M 0.2% 106
2023
Q1 		$266M Sell
845,227
-9,681
-1% -$2.9M 0.2% 109
2022
Q4 		$247M Sell
854,908
-81,147
-9% -$24.7M 0.2% 116
2022
Q3 		$271M Buy
936,055
+7,748
+0.8% +$2.23M 0.22% 104
2022
Q2 		$262M Sell
928,307
-47,077
-5% -$12.6M 0.2% 104
2022
Q1 		$255M Sell
975,384
-64,362
-6% -$15.3M 0.17% 127
2021
Q4 		$228M Sell
1,039,746
-52,295
-5% -$10.2M 0.14% 165
2021
Q3 		$198M Sell
1,092,041
-26,817
-2% -$5.24M 0.12% 183
2021
Q2 		$226M Sell
1,118,858
-135,375
-11% -$28.3M 0.13% 172
2021
Q1 		$270M Sell
1,254,233
-33,649
-3% -$7.39M 0.17% 132
2020
Q4 		$304M Sell
1,287,882
-30,077
-2% -$6.9M 0.2% 119
2020
Q3 		$359M Sell
1,317,959
-16,501
-1% -$4.55M 0.24% 89
2020
Q2 		$387M Buy
1,334,460
+36,251
+3% +$9.83M 0.27% 75
2020
Q1 		$309M Buy
1,298,209
+56,113
+5% +$12.9M 0.27% 79
2019
Q4 		$272M Buy
1,242,096
+20,672
+2% +$4.18M 0.21% 100
2019
Q3 		$207M Buy
1,221,424
+68,293
+6% +$12.1M 0.18% 121
2019
Q2 		$211M Buy
1,153,131
+50,477
+5% +$8.82M 0.19% 114
2019
Q1 		$203M Buy
1,102,654
+30,705
+3% +$5.67M 0.19% 121
2018
Q4 		$173M Buy
1,071,949
+164,403
+18% +$28.5M 0.19% 120
2018
Q3 		$175M Buy
907,546
+17,232
+2% +$3.07M 0.19% 116
2018
Q2 		$151M Buy
890,314
+83,121
+10% +$12.9M 0.18% 128
2018
Q1 		$132M Sell
807,193
-195
-0% -$31.9K 0.17% 134
2017
Q4 		$121M Buy
807,388
+22,338
+3% +$3.31M 0.16% 155
2017
Q3 		$119M Buy
785,050
+8,064
+1% +$1.21M 0.17% 137
2017
Q2 		$100M Buy
776,986
+7,963
+1% +$959K 0.15% 166
2017
Q1 		$84.1M Buy
769,023
+95,144
+14% +$8.38M 0.13% 185
2016
Q4 		$49.6M Sell
673,879
-10,842
-2% -$882K 0.08% 280
2016
Q3 		$59.7M Sell
684,721
-766
-0.1% -$72.4K 0.1% 247
2016
Q2 		$59M Buy
685,487
+19,686
+3% +$1.7M 0.1% 239
2016
Q1 		$52.9M Buy
665,801
+15,452
+2% +$1.4M 0.09% 252
2015
Q4 		$82.2M Buy
650,349
+4,446
+0.7% +$537K 0.15% 157
2015
Q3 		$67.3M Buy
645,903
+26,412
+4% +$3.39M 0.13% 185
2015
Q2 		$76.5M Buy
619,491
+6,271
+1% +$790K 0.14% 176
2015
Q1 		$72.3M Buy
613,220
+67,558
+12% +$8.09M 0.13% 189
2014
Q4 		$65M Sell
545,662
-6,991
-1% -$787K 0.13% 201
2014
Q3 		$62.1M Buy
552,653
+3,371
+0.6% +$321K 0.12% 200
2014
Q2 		$52M Sell
549,282
-25,786
-4% -$1.81M 0.11% 232
2014
Q1 		$40.7M Sell
575,068
-7,494
-1% -$594K 0.09% 270
2013
Q4 		$43M Buy
582,562
+2,699
+0.5% +$188K 0.09% 257
2013
Q3 		$44M Sell
579,863
-1,662
-0.3% -$132K 0.1% 244
2013
Q2 		$46.6M Buy
+581,525
New +$42.8M 0.11% 223

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Sumitomo Mitsui Trust Group's VRTX Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Vertex Pharmaceuticals (VRTX) stake by 0.41% in Q2 2026, selling an estimated $1.13M and leaving 611,907 shares worth $304M. The position accounts for 0.17% of the portfolio, ranked #99.

Sumitomo Mitsui Trust Group first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $387M in Q2 2020. 734 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 611,907 shares of Vertex Pharmaceuticals worth $304M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 2,541 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Vertex Pharmaceuticals made up 0.17% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #99 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui Trust Group's Vertex Pharmaceuticals position peaked at $387M in Q2 2020.
  • 734 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.